BCYC
Price
$8.18
Change
+$0.40 (+5.14%)
Updated
May 8 closing price
Capitalization
538.8M
83 days until earnings call
MLTX
Price
$39.76
Change
+$2.16 (+5.74%)
Updated
May 8, 04:59 PM (EDT)
Capitalization
2.39B
Earnings call today
Ad is loading...

BCYC vs MLTX

Header iconBCYC vs MLTX Comparison
Open Charts BCYC vs MLTXBanner chart's image
Bicycle Therapeutics
Price$8.18
Change+$0.40 (+5.14%)
Volume$493.99K
Capitalization538.8M
MoonLake Immunotherapeutics
Price$39.76
Change+$2.16 (+5.74%)
Volume$23.9K
Capitalization2.39B
BCYC vs MLTX Comparison Chart
Loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCYC vs. MLTX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a StrongBuy and MLTX is a Buy.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (BCYC: $8.18 vs. MLTX: $39.74)
Brand notoriety: BCYC and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 125% vs. MLTX: 159%
Market capitalization -- BCYC: $538.8M vs. MLTX: $2.39B
BCYC [@Biotechnology] is valued at $538.8M. MLTX’s [@Biotechnology] market capitalization is $2.39B. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileMLTX’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • MLTX’s FA Score: 0 green, 5 red.
According to our system of comparison, BCYC is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 5 TA indicator(s) are bullish while MLTX’s TA Score has 9 bullish TA indicator(s).

  • BCYC’s TA Score: 5 bullish, 4 bearish.
  • MLTX’s TA Score: 9 bullish, 1 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than BCYC.

Price Growth

BCYC (@Biotechnology) experienced а -9.91% price change this week, while MLTX (@Biotechnology) price change was -4.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.66%. For the same industry, the average monthly price growth was +15.23%, and the average quarterly price growth was -12.40%.

Reported Earning Dates

BCYC is expected to report earnings on Jul 31, 2025.

MLTX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($2.39B) has a higher market cap than BCYC($539M). MLTX YTD gains are higher at: -30.563 vs. BCYC (-41.571). MLTX has higher annual earnings (EBITDA): -141.71M vs. BCYC (-164.89M). BCYC has more cash in the bank: 880M vs. MLTX (448M). MLTX has less debt than BCYC: MLTX (2.83M) vs BCYC (9.49M). BCYC has higher revenues than MLTX: BCYC (35.3M) vs MLTX (0).
BCYCMLTXBCYC / MLTX
Capitalization539M2.39B23%
EBITDA-164.89M-141.71M116%
Gain YTD-41.571-30.563136%
P/E RatioN/AN/A-
Revenue35.3M0-
Total Cash880M448M196%
Total Debt9.49M2.83M335%
FUNDAMENTALS RATINGS
BCYC: Fundamental Ratings
BCYC
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
86
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYCMLTX
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 2 days ago
43%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 2 days ago
65%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 2 days ago
52%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 2 days ago
61%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 2 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 2 days ago
61%
View a ticker or compare two or three
Ad is loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GTTMX18.150.07
+0.39%
Glenmede Total Market Plus Eq Ptf
CABDX6.13N/A
N/A
AB Relative Value A
NPNRX45.20N/A
N/A
Neuberger Berman Large Cap Value R3
EISAX25.63N/A
N/A
Carillon ClariVest Intl Stock A
WIGOX4.17N/A
N/A
Wasatch Global Opportunities Instl

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with XENE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-4.24%
XENE - MLTX
48%
Loosely correlated
+0.43%
CLDX - MLTX
45%
Loosely correlated
+2.77%
ETNB - MLTX
43%
Loosely correlated
-1.03%
IDYA - MLTX
43%
Loosely correlated
+0.45%
KYMR - MLTX
43%
Loosely correlated
+1.89%
More